NCT01035346View on ClinicalTrials.gov

Study Evaluating The Efficacy Of A Novel Ibuprofen Formulation On Fever In Patients With An Uncomplicated Acute Infection

PHASE3TerminatedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Infection
Interventions
DRUG

Ibuprofen

Single dose of a novel ibuprofen formulation (equal to 400mg ibuprofen)

DRUG

Placebo

Single dose of a placebo

Trial Locations (5)

15241

Pfizer Investigational Site, Pittsburgh

68144

Pfizer Investigational Site, Omaha

84124

Pfizer Investigational Site, Salt Lake City

90630

Pfizer Investigational Site, Cypress

91361

Pfizer Investigational Site, Westlake Village

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY